{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:15:34Z","timestamp":1791267334558,"version":"4.1.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["No. LZ24H310002"],"award-info":[{"award-number":["No. LZ24H310002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a type of metabolic stress-induced liver injury that is closely related to type 2 diabetes mellitus (T2DM). Ursolic acid (UA), a natural pentacyclic triterpenoid compound, has anti-inflammatory, hypoglycemic and liver-protective effects. However, its role in regulating liver injury through the NLRP3 inflammasome pathway in a T2DM combined with NAFLD model has not been systematically elucidated. This study systematically evaluated the protective effect of UA on NAFLD and its molecular mechanism through in vivo (STZ\u2009+\u2009high-fat diet-induced NAFLD mouse model) and in vitro (high glucose\u2009+\u2009palmitic acid-induced LO2 cell oxidative stress model) experiments. The results showed that UA significantly improved hepatic lipid deposition, reduced serum ALT\/AST levels, and effectively alleviated oxidative stress, as indicated by decreased malondialdehyde (MDA) content and increased activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) in liver tissues. Further mechanism studies revealed that UA could significantly down-regulate the expression levels of pro-inflammatory factor IL-1\u03b2 and pro-fibrotic factor TGF-\u03b21 by inhibiting NLRP3 inflammasome activation, and simultaneously reduce the deposition of type IV collagen. This study demonstrated that ursolic acid (UA) has a protective effect on T2DM combined with NAFLD, and its mechanism of action may be related to the regulation of the NLRP3 signaling pathway by UA, which inhibits oxidative stress, inflammation and fibrosis.<\/jats:p>","DOI":"10.1371\/journal.pone.0340643","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:33:43Z","timestamp":1770230023000},"page":"e0340643","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ursolic acid alleviates liver injury in diabetic mice induced by high-fat diet combined with streptozotocin via the NLRP3 signaling pathway"],"prefix":"10.1371","volume":"21","author":[{"given":"Xinyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-4080","authenticated-orcid":true,"given":"Minyou","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"issue":"1","key":"pone.0340643.ref001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"S Pouwels","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"pone.0340643.ref002","doi-asserted-by":"crossref","first-page":"111648","DOI":"10.1016\/j.diabres.2024.111648","article-title":"Epidemiology of NAFLD - Focus on diabetes","volume":"210","author":"ZM Younossi","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"pone.0340643.ref003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.11.015","article-title":"Physical exercise and liver \u201cfitness\u201d: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease","volume":"32","author":"J Stevanovi\u0107","year":"2020","journal-title":"Mol Metab"},{"key":"pone.0340643.ref004","doi-asserted-by":"crossref","first-page":"105484","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: Targets and therapy","volume":"167","author":"N Sodum","year":"2021","journal-title":"Pharmacol Res"},{"issue":"2","key":"pone.0340643.ref005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"N Esser","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"pone.0340643.ref006","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-319-48382-5_12","article-title":"Insulin Resistance, Obesity and Lipotoxicity","volume":"960","author":"D Yazici","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"pone.0340643.ref007","doi-asserted-by":"crossref","first-page":"2456579","DOI":"10.1155\/2018\/2456579","article-title":"Diabetes Mellitus and Liver Surgery: The Effect of Diabetes on Oxidative Stress and Inflammation","volume":"2018","author":"M Mendes-Braz","year":"2018","journal-title":"Mediators Inflamm"},{"issue":"2","key":"pone.0340643.ref008","article-title":"NLRP3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes","volume":"10","author":"IM Gora","year":"2021","journal-title":"Cells"},{"issue":"8","key":"pone.0340643.ref009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084537","article-title":"NLRP3 inflammasome in acute and chronic liver diseases","volume":"25","author":"K Sayaf","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0340643.ref010","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051097","article-title":"Pathophysiology and treatment options for hepatic fibrosis: can it be completely cured?","volume":"10","author":"A Khanam","year":"2021","journal-title":"Cells"},{"key":"pone.0340643.ref011","doi-asserted-by":"crossref","first-page":"198965","DOI":"10.1016\/j.virusres.2022.198965","article-title":"A therapeutic agent of ursolic acid demonstrates potential application in aquaculture","volume":"323","author":"B-Y Li","year":"2023","journal-title":"Virus Res"},{"issue":"1","key":"pone.0340643.ref012","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12935-022-02804-7","article-title":"Ursolic acid: a natural modulator of signaling networks in different cancers","volume":"22","author":"S Zafar","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"16","key":"pone.0340643.ref013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165920","article-title":"Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: An Update","volume":"21","author":"V Khwaza","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pone.0340643.ref014","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/antiox10081161","article-title":"Ursolic Acid and Related Analogues: Triterpenoids with Broad Health Benefits","volume":"10","author":"HN Nguyen","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"pone.0340643.ref015","doi-asserted-by":"crossref","first-page":"1251248","DOI":"10.3389\/fvets.2023.1251248","article-title":"Ursolic acid: biological functions and application in animal husbandry","volume":"10","author":"G Liu","year":"2023","journal-title":"Front Vet Sci"},{"key":"pone.0340643.ref016","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.foodres.2017.10.028","article-title":"Recent developments on the extraction and application of ursolic acid. A review","volume":"103","author":"L L\u00f3pez-Hortas","year":"2018","journal-title":"Food Res Int"},{"issue":"11","key":"pone.0340643.ref017","doi-asserted-by":"crossref","first-page":"10614","DOI":"10.18632\/aging.103282","article-title":"Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4\/ROS and RhoA\/ROCK1 signalling pathways","volume":"12","author":"S Wan","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"pone.0340643.ref018","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5650\/jos.ess21258","article-title":"Anti-obesity and Anti-diabetic Effect of Ursolic Acid against Streptozotocin\/High Fat Induced Obese in Diabetic Rats","volume":"71","author":"S Tang","year":"2022","journal-title":"J Oleo Sci"},{"issue":"7","key":"pone.0340643.ref019","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"SL Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"pone.0340643.ref020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11892-021-01383-7","article-title":"The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk","volume":"21","author":"C Caussy","year":"2021","journal-title":"Curr Diab Rep"},{"issue":"11","key":"pone.0340643.ref021","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/nu10111719","article-title":"Ursolic Acid Attenuates Hepatic Steatosis, Fibrosis, and Insulin Resistance by Modulating the Circadian Rhythm Pathway in Diet-Induced Obese Mice","volume":"10","author":"E-Y Kwon","year":"2018","journal-title":"Nutrients"},{"issue":"8","key":"pone.0340643.ref022","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12032-025-02854-7","article-title":"Protective role of ursolic acid against cisplatin-induced oxidative stress and ferroptosis in the liver of Swiss albino mice","volume":"42","author":"S Kannampuzha","year":"2025","journal-title":"Med Oncol"},{"key":"pone.0340643.ref023","doi-asserted-by":"crossref","first-page":"8609213","DOI":"10.1155\/2020\/8609213","article-title":"Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus","volume":"2020","author":"H Yaribeygi","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"5963","key":"pone.0340643.ref024","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger?","volume":"327","author":"K Schroder","year":"2010","journal-title":"Science"},{"issue":"4","key":"pone.0340643.ref025","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jcpe.13258","article-title":"NLRP3 inflammasome mediates M1 macrophage polarization and IL-1\u03b2 production in inflammatory root resorption","volume":"47","author":"J Zhang","year":"2020","journal-title":"J Clin Periodontol"},{"issue":"3","key":"pone.0340643.ref026","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Y-H Youm","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"pone.0340643.ref027","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"S Gaul","year":"2021","journal-title":"J Hepatol"},{"key":"pone.0340643.ref028","doi-asserted-by":"crossref","first-page":"109099","DOI":"10.1016\/j.intimp.2022.109099","article-title":"Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob\/ob mice","volume":"111","author":"L-C Meng","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"pone.0340643.ref029","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"P Horn","year":"2024","journal-title":"Cell Metab"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:33:51Z","timestamp":1770230031000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0340643"}},"subtitle":[],"editor":[{"given":"Kota V","family":"Ramana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0340643","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}